Cardiovascular Risk Assessment in a Cohort of Newly Diagnosed Patients with Obstructive Sleep Apnea Syndrome

Abstract EN

Objectives.

Obstructive sleep apnea syndrome (OSAS) is associated with increased cardiovascular morbidity and mortality.

The aim of this study was to assess whether the 10-year risk for cardiovascular disease in newly diagnosed patients with OSAS is increased.

Materials and Methods.

Recently diagnosed, with polysomnography, consecutive OSAS patients were included.

The Systematic Coronary Risk Evaluation (SCORE) and the Framingham Risk Score (FRS) were used to estimate the 10-year risk for cardiovascular disease.

Results.

Totally, 393 individuals (73.3% males), scheduled to undergo a polysomnographic study with symptoms indicative of OSAS, were enrolled.

According to apnea-hypopnea index (AHI), subjects were divided in four groups: mild OSAS (AHI 5–14.9/h) was diagnosed in 91 patients (23.2%), moderate OSAS (AHI 15–29.9/h) in 58 patients (14.8%), severe OSAS (AHI > 30/h) in 167 patients (42.5%), while 77 individuals (19.6%) had an AHI < 5/h and served as controls.

Increased severity of OSAS was associated with increased SCORE p<0.001 and FRS values p<0.001.

More specifically, a significant correlation was observed both between AHI and SCORE r=0.251, p<0.001 and AHI and FRS values r=0.291, p<0.001.

Furthermore, a negative correlation was observed between FRS values and sleep efficiency r=−0.224, p=0.006.

Conclusions.

The 10-year risk for cardiovascular morbidity and mortality seems to increase with severity of OSAS.

Physicians should bear this finding in mind, in order to seek for and consecutively eliminate risk factors for cardiovascular disease and to prevent future cardiovascular events in OSAS patients.